Tabletting Technology Course

25 - 27 November 2019, London

Tabletting Technology for the Pharmaceutical Industry is an introduction to tabletting and associated processes, offering a unique opportunity for you to discuss real day-to-day challenges with industry experts. 

Lifecycleofmedicine

Join us on this well-established and intensive 3-day course for an in-depth look at the formulation, production and drug-release characteristics of pharmaceutical tablets.

We'll be working with UCL School of Pharmacy for a hands-on demonstration taking place at the UCL School of Pharmacy. 

Want to know more? See below for information on the programme, speakers and venue.

Book your place today

For RPS members - £1,300

For non-members - £1,600

Book now


You'll save £300 on the cost of your ticket by becoming a member of the RPS.

If you'd like to discuss group booking discounts please contact the events team directly [email protected].

Programme

Day 1 - Monday 25 November Day 1 - Monday 25 November

Please note the programme is subject to change.

09:30 Registration
10:15

Introduction
Kendal Pitt, GlaxoSmithKline

10:45

An introduction to tablet formulation
Michael Wilkins, Almac Pharma Services

12:00

Material properties of importance for tabletting (I)
Michael Wilkins, Almac Pharma Services

12:30

Material properties of importance for tabletting (II)
Michael Wilkins, Almac Pharma Services

13:00 Lunch
14:00

A brief introduction to modified release
Kendal Pitt, GlaxoSmithKline

14:30

Dissolution testing
Kendal Pitt, GlaxoSmithKline

15:00

Problem based learning 1: Active Pharmaceutical Ingredient (API)
Kendal Pitt, GlaxoSmithKline

Problem based learning 2: Formulation development
Michael Wilkins, Almac Pharma Services

15:45 Afternoon refreshments
16:00

Problem based learning continued

17:00

Sponsor presentation

17:30 Close

 

Book now

Day 2 - Tuesday 26 November Day 2 - Tuesday 26 November

 

08:30

Tabletting machines and in-process control
Brian Helsdon, Consultant 

09:30

Punch design
Steve Osborn, Director, I Holland

10:30 Morning refreshments
10:45

Compaction simulation
Kendal Pitt, GlaxoSmithKline

11:45

Packaging: Key concepts
Michael Wilkins, Almac Pharma Services

12:30 Lunch and transport to UCL School of Pharmacy
14:00

Tabletting demonstration - Group A
UCL School of Pharmacy

Scenario testing - Group B
Tesh Patel, Consultant

15:30

Scenario testing - Group A
Tesh Patel, Consultant

Tabletting demonstration - Group B
UCL School of Pharmacy

17:00 Review of day
17:30 Close
17:30 - 20:30 Social programme - Private dining

 

 

Book now

Day 3 - Wednesday 27 November Day 3 - Wednesday 27 November

 

08:30

Process Analytical Technolgy (PAT) applied to tabletting
Sander van den Ban, GlaxoSmithKline

09:30

Wet granulation product & process design, characterisation and control
Christian Seiler, PharmaXP Consulting

10:15 Morning refreshments
10:30

Scale-up, Quality-by-Design and technology transfer of wet granulated products
Christian Seiler, PharmaXP Consulting

11:15

Roller Compaction
Kendal Pitt, GlaxoSmithKline

12:00

Film Coating Formulation
Marshall Whiteman, Quindell Consulting

12:45 Lunch
13:30

Film Coating Processes 
Marshall Whiteman, Quindell Consulting

14:15

Compaction characterisation and process understanding
Kendal Pitt, GlaxoSmithKline

15:00 Concluding discussion
15:30 Close

 

Book now

Speakers

Brian Helsdon

Consultant / Product Expert




Biography Biography

An engineer with 45+ years’ experience of the Manesty / Bosch  products, Brian Helsdon has a wide knowledge of tableting equipment gained as result of many years working within the production and engineering departments at Manesty in a number of senior roles. 

Brian was responsible for Manesty's customer training and product support worldwide up to his retirement in November 2012.

He now as part of Bosch Management Support (BMS) offers consulting, support & training in tablet compression technology, tablet coating equipment and tablet tooling. 

Tesh Patel

Independent Consultant


Biography Biography

Dr Patel is a PhD Pharmacist from Portsmouth and Manchester Universities, an eligible EU Qualified Person and currently an Independent Consultant. Dr Patel was previously with Astellas for nearly 10 years as their Executive Director, Head of Quality Assurance - EMEA; Astellas Pharma EMEA.

Prior to Astellas, he worked for Abbott Laboratories for fourteen years and ICI / Zeneca Pharmaceuticals for nine years. At Abbott, he held positions of Technical Services Manager, Manufacturing Manager, QA Product Surveillance Manager, Divisional Quality Manager (Europe/Japan) and Commercial QA Manager (Europe). 

Dr Patel's specialist field is in the development and manufacture of solid and liquid dosage pharmaceuticals, and was a member of both the Royal Societies of Chemistry and Pharmacy and of the Chartered Management Institute.

Kendal Pitt

Senior Technical Director in Global Manufacturing, GlaxoSmithKline 


Biography Biography

Kendal G. Pitt, Ph.D (London University), B.Pharm (University of Nottingham), is a Senior Technical Director in Global Manufacturing and Supply for GlaxoSmithKline based at Ware, UK. 

He is a a Fellow of the Royal Pharmaceutical Society (FRPharmS) and a Fellow of the Academy of Pharmaceutical Sciences (FAPS). Kendal has worked in the Pharmaceutical Industry for over 30 years, with Wellcome Foundation Ltd., Roche Pharmaceuticals and more recently for Merck. He has headed groups in both the United States and Great Britain and has led project teams responsible for the successful filing and launch of both tablets and freeze-dried oral dosage forms.

Primary research interests are in powder compaction, powder flow and granulation process optimisation, including the use of compaction simulators in tablet and capsule product development. He has additionally published in the areas of formulation and design for nasal delivery of pharmaceuticals and on statistical design of experiments, and has co-authored chapters on formulation, tabletting and on strength testing. 

Christian Seiler

Chairman, Pharma Xp Consulting Limited and Global Technical Head, Cmc / Pharmaceutical Development, Viiv Healthcare

Biography Biography

Christian holds a masters degree in Chemical Engineering from the University of Karlsruhe, Germany, and a PhD in Chemical Engineering from the University of Birmingham, UK. 

Christian has been working in the pharmaceutical industry for the past 17 years and is currently Global Technical Head, CMC / Pharmaceutical Development, of ViiV Healthcare, a pharmaceutical company with 100% focus on HIV therapies, which is owned by GlaxoSmithKline, Pfizer & Shionogi. He is also chairman of Pharma XP Consulting Limited, a company providing technical & strategic consultancy to the pharmaceutical sector, for which he served as Managing Director from 2014 to 2016 (until joining the staff of ViiV Healthcare). Prior to this, Christian worked in the Research Laboratories of Merck/MSD (2000-2014), where he was a Senior Principal Scientist, Formulation Sciences group leader, Controlled Release Centre of Excellence leader (2007-2013) and member of the Innovation Strategy Board in Pharmaceutical Sciences & Clinical Supply (2011-2014).

Christian has been active in the scientific community for many years, having presented at many conferences, supervised a number of University research projects (including PhDs) and served on various scientific committees, mainly for the Institution of Chemical Engineers (IChemE), the Royal Society of Chemistry (RSC) and the Controlled Release Society (CRS).

Christian’s primary research interests / expertise are in the areas of powder granulation, particle coating and oral controlled release formulation development, with broad experience in all aspects of oral solid dosage form development.

Sander van den Ban

Head of Formulation Sciences, Reckitt Benckiser

Biography Biography

Sander van den Ban is the Head of Formulation Sciences for Reckitt Benckiser R&D based at Hull, UK. He holds a masters degree in “Chemical Technology and Materials Science” from the University of Delft, the Netherlands and graduated with distinction in the field of explosion science.

He is a Fellow of the Institute of Chemical Engineers. He has worked in the Pharmaceutical Industry for over 10 years for GSK and more recently for RB in various positions in Research and Development, Process Design and Development, and Manufacturing and is experienced in development, transfer, introduction of well understood reliable manufacturing processes for tablet dosage forms from R&D into manufacturing with particular focus on QbD and interaction with regulatory agencies.

Marshall Whiteman 

Senior Technical Director, GlaxoSmithKline 

 

Biography Biography

Marshall Whiteman obtained his B.Pharm. and Ph.D. from the London School of Pharmacy.He has worked in within the pharmaceutical industry for over 30 years, with Wyeth Laboratories, Smith, Kline & French/SmithKline Beecham and GSK

He played key technical roles with two start-up pharmaceutical companies, Phoqus Pharmaceuticals Limited (developing electrostatic powder deposition technology for drug delivery), and Neuropharm Limited (developing treatments for Autism and Fragile X syndrome) and as a consultant has led transfers of manufacturing technology for HIV medicines to BRIC countries.

He is currently a Senior Technical Director within the Pharma Supply Chain organisation of GlaxoSmithKline plc.

Michael Wilkins  

Head of Formulation & Process Development, Almac Group

Biography Biography

Dr Wilkins graduated in Pharmacy from Sunderland School of Pharmacy and was awarded his PhD from The University of Nottingham. In 1994, he joined SmithKline Beecham Pharmaceuticals working in Pharmaceutical Development on solid oral dosage formulations. In 2002 he moved to Fournier Laboratories Ireland as the Head of Pharmaceutical Sciences, working on nanoparticulate formulations and combination products. In 2006, he returned to GlaxoSmithKline to work on the transfer of development projects in to commercial manufacture, with a particular focus on QbD applications and interactions with US, European and International regulatory agencies. In 2010, Dr Wilkins joined the Almac Group and is currently the Head of Formulation & Process Development.

Venue 

VIL_7781_wb_outsidetree

Royal Pharmaceutical Society
66 East Smithfield
London
E1W 1AW

Get directions